| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/23/1997 | EP0769065A1 Methods for identifying inhibitors of integrin activation |
| 04/23/1997 | EP0769060A1 Fas associated proteins |
| 04/23/1997 | EP0769058A1 Nucleic acid fragments and corresponding peptide fragments from the caprine arthritis-encephalitis virus (caev) genome, and uses thereof |
| 04/23/1997 | EP0769057A1 RECOMBINANT MONO AND POLY ANTIGENS TO DETECT CYTOMEGALOVIRUS-SPECIFIC IgM IN HUMAN SERA BY ENZYME IMMUNOASSAY |
| 04/23/1997 | EP0769056A1 NON-SPLICING VARIANTS OF gp350/220 |
| 04/23/1997 | EP0769055A1 Variants of leukemia inhibitory factor |
| 04/23/1997 | EP0769054A1 Immunomodulators |
| 04/23/1997 | EP0769053A2 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma |
| 04/23/1997 | EP0769052A2 Mammalian peroxisome proliferator-activated receptors and uses thereof |
| 04/23/1997 | EP0769024A1 High-affinity melatonin receptors and uses thereof |
| 04/23/1997 | EP0769023A1 Retinoic acid receptor epsilon |
| 04/23/1997 | EP0769022A1 O-glycosylated authentic igf-i and truncated variants thereof, a method of preparation thereof and pharmaceutical compositions |
| 04/23/1997 | EP0769021A2 Transgenic fish in the treatment of diabetes |
| 04/23/1997 | EP0769020A1 NEW hIL-4 MUTANT PROTEINS USED AS ANTAGONISTS OR PARTIAL AGONISTS OF HUMAN INTERLEUKIN 4 |
| 04/23/1997 | EP0769019A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 04/23/1997 | EP0769018A1 Helicobacter proteins and vaccines |
| 04/23/1997 | EP0768893A1 Polynucleotide vaccine for papillomavirus |
| 04/23/1997 | EP0768890A1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 04/23/1997 | EP0768869A1 Factor to grow tissue ex vivo |
| 04/23/1997 | EP0768821A1 pp60PIK : A DOWNSTREAM ELEMENT IN INSULIN SIGNALING |
| 04/23/1997 | EP0749472A4 Extracorporeal cell culture and transplantation kits |
| 04/23/1997 | EP0707599B1 Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
| 04/23/1997 | EP0624196B1 Polypeptides with fibronectin binding sites as modulators for matrix assembly |
| 04/23/1997 | EP0621869B1 Human kunitz-type protease inhibitor variants |
| 04/23/1997 | EP0502956B1 Production of recombinant human interleukin-1 inhibitor |
| 04/23/1997 | EP0495049B1 Process for the enzymatic preparation of basic fibroblast growth factor |
| 04/23/1997 | EP0401254B1 Methods for controlling norleucine content in polypeptides |
| 04/23/1997 | EP0400047B1 Modified hepatocytes and uses therefor |
| 04/23/1997 | EP0394418B1 Osteogenic factors |
| 04/23/1997 | CN1148408A Hematopoietic Protein and materials and method for making it |
| 04/23/1997 | CN1148407A Modulators of anchoring protein function |
| 04/23/1997 | CN1148394A Prostaglandin E receptor |
| 04/23/1997 | CN1148342A Lymphoblastoid natural interferon alpha production |
| 04/23/1997 | CN1034672C Alpha or beta chains dimeric compound of inhibitor for human being or pigs, and method for producing same |
| 04/23/1997 | CN1034663C Method for preparing hemoregulatory peptides |
| 04/22/1997 | US5623067 Isolated dna fragment comprising seed-specific promoter region of arabidopsis thaliana gene coding for precursor of 2s albumin |
| 04/22/1997 | US5623058 Medical diagnosis; complexing using dimethylethylaminopropylcarbodiimide |
| 04/22/1997 | US5623057 Pneumococcal polysaccharide conjugate vaccine |
| 04/22/1997 | US5623056 Immunomodulators |
| 04/22/1997 | US5623054 Crucifer AFT proteins and uses thereof |
| 04/22/1997 | US5623053 Heterodimer comprising beta-2-microglobulin light chain and heavy chain derived from mammalian membrane-bound fc receptor by truncating to include only extracellular domains |
| 04/22/1997 | US5623052 Oligopeptide |
| 04/22/1997 | US5623051 Methods and compositions for screening for presynaptic calcium channel blockers |
| 04/22/1997 | US5623050 Stable polypeptides having c-AMP production enhancing activity and the use thereof |
| 04/22/1997 | US5623049 Flexible antisense agents comprising oligonuceotides having the (deoxy)ribose backbone replaced by an oligopeptide; protease- and nuclease-resistant; viricides; attached to carriers able to penetratate in cells |
| 04/22/1997 | US5622935 Medicine for preventing and curing bone fracture |
| 04/22/1997 | US5622933 Multiple branch peptide constructions for use against HIV |
| 04/22/1997 | US5622932 IGF-1 superagonists |
| 04/22/1997 | US5622931 Human tissue factor related DNA segments, polypeptides and antibodies |
| 04/22/1997 | US5622930 C1 inhibitor muteins and uses thereof |
| 04/22/1997 | US5622929 Anthracycline antibiotic; antitumor agent binds with a target cell |
| 04/22/1997 | US5622928 Glia activation factor and its production |
| 04/22/1997 | US5622862 A cell line encoding tyrosine kinase receptor protein treating neurological disorders |
| 04/22/1997 | US5622861 Recombinant DNA encoding hepatitis A virus receptor |
| 04/22/1997 | US5622860 Genes encoding melanocortin receptors |
| 04/22/1997 | US5622856 High efficiency helper system for AAV vector production |
| 04/22/1997 | US5622852 Polynucleotide comprising sequence encoding mammalian bcl-xl/bcl-2 associated death promoter polypeptide |
| 04/22/1997 | US5622845 Fermentation method for producing norleucine |
| 04/22/1997 | US5622843 Phospholipid transfer proteins and DNA encoding them |
| 04/22/1997 | US5622840 Method for controlling gene expression |
| 04/22/1997 | US5622839 Recombinant production of human calcitonin receptor polypeptides |
| 04/22/1997 | US5622838 DNA preparation coding for ricin A and methods of using same |
| 04/22/1997 | US5622829 Genetic engineering |
| 04/22/1997 | US5622828 Contacting mixture of nucleic acids with secretory phospholipase a2, partitioning increased affinity nucleic acids, amplifying |
| 04/22/1997 | US5622706 Synthetic polypeptide comprising amino acid sequence of mature stx gene; accellular vaccines |
| 04/22/1997 | US5622705 Insertion nucleotide sequence into cell to stimulate immuneresponse |
| 04/22/1997 | US5622703 Immunodominant sites of HTLV-I envelope protein |
| 04/22/1997 | US5622702 Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease |
| 04/19/1997 | CA2188092A1 A method for the quantification of actived coagulation factor vii (fvlla) |
| 04/17/1997 | WO1997014038A1 Methods to identify modulators of cell signaling |
| 04/17/1997 | WO1997013867A1 Retroviral vectors carrying senescent cell derived inhibitors 1 (sdi-1) or antisense sdi-1 nucleotide sequences |
| 04/17/1997 | WO1997013866A2 Recombinant herpes virus vectors for expression in neuronal cells |
| 04/17/1997 | WO1997013864A1 Juvenile hormone or one of its agonists as a chemical ligand to control gene expression in plants by receptor mediated transactivation |
| 04/17/1997 | WO1997013863A1 Use of a sec-dependent secretion system for secreting proteins that are usually secreted by a sec-independent secretion system |
| 04/17/1997 | WO1997013861A1 Composition and method of imparting resistivity to hiv superinfection to cells |
| 04/17/1997 | WO1997013860A1 Neisseria meningitidis subunit tbp2 |
| 04/17/1997 | WO1997013859A1 A novel haematopoietic cytokine and uses therefor |
| 04/17/1997 | WO1997013858A2 Baboon mage-3 homologs, dna encoding the homologs, and a process for their use |
| 04/17/1997 | WO1997013857A1 Combination pdgf, kgf, igf and igfbp for wound healing |
| 04/17/1997 | WO1997013856A1 Improvements in or relating to protection against intracellular infection |
| 04/17/1997 | WO1997013855A1 Melanoma-associated protein |
| 04/17/1997 | WO1997013854A1 Pilosulin 2 |
| 04/17/1997 | WO1997013853A2 Protein detection |
| 04/17/1997 | WO1997013852A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 04/17/1997 | WO1997013848A1 Cd23 processing enzyme preparation |
| 04/17/1997 | WO1997013847A1 Expression system, vector and cell transformed thereby |
| 04/17/1997 | WO1997013843A1 Production of water stress or salt stress tolerant transgenic cereal plants |
| 04/17/1997 | WO1997013841A1 Separation and concentration systems based on soluble oligosaccharide binding domains |
| 04/17/1997 | WO1997013787A1 Vegf-binding polypeptide |
| 04/17/1997 | WO1997013786A1 Streptoccal inhibitor of complement-mediated lysis, protein sic |
| 04/17/1997 | WO1997013785A1 Transferrin receptor protein of moraxella |
| 04/17/1997 | WO1997013784A1 Helicobacter lactoferrin receptor |
| 04/17/1997 | WO1997013781A2 Synthetic peptides that inhibit il-6 activity |
| 04/17/1997 | WO1997013778A1 A metastasis suppressor gene |
| 04/17/1997 | WO1997013530A1 USE OF A VECTOR CAUSING Bcl-2 EXPRESSION OR A TEMPORARY INCREASE IN Bcl-2 ACTIVITY |
| 04/17/1997 | WO1997013524A1 Use of a polypeptide having soluble human cd16 activity for treating hiv infection |
| 04/17/1997 | WO1997013522A1 Generating d-peptides: methods and compositions |
| 04/17/1997 | WO1997013410A1 Hybrid molecules containing amidated polypeptide binding ligands |
| 04/17/1997 | WO1997013402A1 Modified bacillus thuringiensis gene for lepidopteran control in plants |
| 04/17/1997 | WO1997013401A1 Method for the production of hybrid plants |